WO2007133711A3 - Pharmaceutical compositions for vein irritating drugs - Google Patents

Pharmaceutical compositions for vein irritating drugs Download PDF

Info

Publication number
WO2007133711A3
WO2007133711A3 PCT/US2007/011465 US2007011465W WO2007133711A3 WO 2007133711 A3 WO2007133711 A3 WO 2007133711A3 US 2007011465 W US2007011465 W US 2007011465W WO 2007133711 A3 WO2007133711 A3 WO 2007133711A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical compositions
formulations
vein irritating
vein
irritating drugs
Prior art date
Application number
PCT/US2007/011465
Other languages
French (fr)
Other versions
WO2007133711A2 (en
WO2007133711B1 (en
Inventor
Andrew Xian Chen
Original Assignee
Adventrx Pharmaceuticals Inc
Andrew Xian Chen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adventrx Pharmaceuticals Inc, Andrew Xian Chen filed Critical Adventrx Pharmaceuticals Inc
Priority to EP07777015A priority Critical patent/EP2023895A2/en
Priority to CA002651988A priority patent/CA2651988A1/en
Publication of WO2007133711A2 publication Critical patent/WO2007133711A2/en
Publication of WO2007133711A3 publication Critical patent/WO2007133711A3/en
Publication of WO2007133711B1 publication Critical patent/WO2007133711B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Non-vein irritating pharmaceutical formulations (e.g., oil-in-water emulsions, frozen formulations, and lyophilized formulations) of vancomycin and clarithromycin are provided. Also provided are methods for preparing and using such formulations.
PCT/US2007/011465 2006-05-12 2007-05-11 Pharmaceutical compositions for vein irritating drugs WO2007133711A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP07777015A EP2023895A2 (en) 2006-05-12 2007-05-11 Pharmaceutical compositions for vein irritating drugs
CA002651988A CA2651988A1 (en) 2006-05-12 2007-05-11 Pharmaceutical compositions for vein irritating drugs

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80013306P 2006-05-12 2006-05-12
US60/800,133 2006-05-12

Publications (3)

Publication Number Publication Date
WO2007133711A2 WO2007133711A2 (en) 2007-11-22
WO2007133711A3 true WO2007133711A3 (en) 2008-01-24
WO2007133711B1 WO2007133711B1 (en) 2008-03-13

Family

ID=38599386

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/011465 WO2007133711A2 (en) 2006-05-12 2007-05-11 Pharmaceutical compositions for vein irritating drugs

Country Status (5)

Country Link
EP (1) EP2023895A2 (en)
CN (1) CN101472562A (en)
CA (1) CA2651988A1 (en)
TW (1) TW200812608A (en)
WO (1) WO2007133711A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011520889A (en) 2008-05-15 2011-07-21 バクスター・インターナショナル・インコーポレイテッド Stable pharmaceutical formulation
KR101793101B1 (en) * 2010-08-20 2017-11-02 닥터 레디스 래보러토리즈 에스에이 Phospholipid depot
AU2015202240B2 (en) * 2010-08-20 2016-09-29 Dr. Reddy's Laboratories Sa Phospholipid depot
NZ608406A (en) * 2010-10-22 2015-06-26 Reddy’S Lab Inc Dr Use of storage stable viscous phospholipid depot to treat wounds
CN103330734B (en) * 2013-06-21 2015-02-04 辽宁海思科制药有限公司 Medium/long-chain fat emulsion injection pharmaceutical composition and preparation method thereof
AU2015229069A1 (en) 2014-03-14 2016-11-03 CutisPharma,Inc. Composition and method for vancomycin oral liquid
CN107904286A (en) * 2017-12-27 2018-04-13 苏州普瑞森基因科技有限公司 A kind of colorectal cancer microbial markers and its application

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005016308A1 (en) * 2003-08-06 2005-02-24 Sd Pharmaceuticals, Inc. Macrolides containing oil-in-water emulsions
WO2006017246A2 (en) * 2004-07-12 2006-02-16 Sd Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005016308A1 (en) * 2003-08-06 2005-02-24 Sd Pharmaceuticals, Inc. Macrolides containing oil-in-water emulsions
WO2006017246A2 (en) * 2004-07-12 2006-02-16 Sd Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LOVELL M W ET AL: "Less-painful emulsion formulations for intravenous administration of clarithromycin", INTERNATIONAL JOURNAL OF PHARMACEUTICS (AMSTERDAM), vol. 109, no. 1, 1994, pages 45 - 57, XP002459205, ISSN: 0378-5173 *

Also Published As

Publication number Publication date
CN101472562A (en) 2009-07-01
TW200812608A (en) 2008-03-16
WO2007133711A2 (en) 2007-11-22
CA2651988A1 (en) 2007-11-22
WO2007133711B1 (en) 2008-03-13
EP2023895A2 (en) 2009-02-18

Similar Documents

Publication Publication Date Title
WO2007133711A3 (en) Pharmaceutical compositions for vein irritating drugs
WO2008057550A3 (en) Stabilization of vaccines by lyophilization
WO2007134279A3 (en) Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
WO2009121039A3 (en) Administration of benzodiazepine compositions
WO2004093795A3 (en) Compositions for delivery of drug combinations
WO2008049116A3 (en) Substituted indoles
WO2007100902A3 (en) Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
WO2008073448A3 (en) Pharmaceutical formulations and methods for making the same
TW200744665A (en) Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
WO2011008495A3 (en) Arginase formulations and methods
WO2008061014A3 (en) Self-assembling peptide amphiphiles for tissue engineering
WO2008115469A3 (en) Role of hedgehog signaling in atherosclerosis and cardiovascular disease
PT1879655E (en) Pharmaceutical composition comprising an anti-bacterial agent and an active ingredient selected from carveol, carvacrol, alpha-ionone, beta-ionone, and thymol
WO2006002077A3 (en) Stable pharmaceutical formulations of benzimidazole compounds
WO2011128627A8 (en) Oral veterinary pharmaceutical and nutraceutical compositions
EP3381445A3 (en) Aqueous formulation of antibody stablised by antioxidants for parenteral administration
WO2010021607A3 (en) Pharmaceutical formulation
WO2008088779A3 (en) Solid state forms of 5-azacytidine and processes for preparation thereof
WO2007067784A3 (en) Liposomal compositions
WO2005071067A3 (en) Non-animal origin stabilizers and processes for producing the same
WO2007110709A8 (en) Formulations of tipifarnib for intravenous administration
WO2008128191A3 (en) Oral cephalotaxine dosage forms
WO2009026257A8 (en) Methods and compositions for controlling the bioavailability of poorly soluble drugs
WO2008022263A3 (en) Methods for lymph system imaging
WO2008100290A3 (en) Recombinant rhinovirus vectors

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780022802.0

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07777015

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2651988

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007777015

Country of ref document: EP